Skip to Main Content

Paper Details

Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older.
JAMA Netw Open
12
2022
Author NameAffiliation
Ran D BalicerClalit Research Institute, Clalit Health Services
Ran D BalicerClalit Health Services
Ran D BalicerSchool of Public Health, Ben Gurion University
  • 1 - 3

Datasets

Release 1.2